Use, safety and Tolerability of IntraVenous epOprostenoL (Veletri®) in patients with severe pulmonary arterIal hypertension: A 6-month, open label, multicenter,observational, non-interventional study (TIVOLI) First published 29/11/2019 Last updated 18/09/2024 EU PAS number:EUPAS32492 Study Finalised